physiopathology significance asymptomatic airway hyperresponsiveness ahr defined period compared clinical immunologic physiologic features NUMBER subjects asymptomatic ahr NUMBER symptomatic asthmatic subjects NUMBER normoresponder subjects age NUMBER NUMBER yr mean sem n NUMBER subject completed respiratory questionnaire underwent spirometry measurement bronchodilator response peak expiratory flows allergy test blood eosinophil count assay total serum ige level methacholine challenge tests repeated annually period year NUMBER yr subjects asymptomatic ahr greater bronchodilator responses p NUMBER variability peak expiratory flow rate pefr p NUMBER prevalence atopy p NUMBER did normoreactive subjects compared asthmatic subjects subjects asymptomatic ahr lower blood eosinophil count p NUMBER higher mean fev1 p NUMBER weaker bronchodilator response p NUMBER greater perception bronchoconstriction p NUMBER NUMBER yr concentration methacholine provoking NUMBER decrease fev1 pc20 decreased significantly asymptomatic ahr subjects p NUMBER compared groups NUMBER subjects studied time NUMBER developed asthma symptoms subjects atopic exposed animals developed asthma familial history asthma increased baseline ahr compared subjects did develop symptoms conclusion study shows period subjects asymptomatic ahr greater increase airway responsiveness frequency development asthma symptoms did normoresponsive subjects allergen exposure sensitized subjects time study genetic predisposition main risk factors development symptomatic asthma population NUMBER yr skin prick NUMBER yr